Thrombocytopenia Alloimmune
1 clinical trials · Condition
◉ Watch Thrombocytopenia Alloimmune
| Record | Firm | Date |
|---|---|---|
| An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia (NCT06337474) | Changzhou No.2 People's Hospital | 2024-08-30 |
Track Thrombocytopenia Alloimmune automatically
Every clearance here is in the API, with alerts when new ones post.